Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decision regret and shared decision-making in patients undergoing hyperbaric oxygen therapy.

Diving and hyperbaric medicine·2026
Same author

Transgender people and occupational diving: a new challenge for diving physicians?

Diving and hyperbaric medicine·2026
Same author

Dermatologic indications for microwave-induced local hyperthermia.

The Journal of dermatological treatment·2026
Same author

Functional outcome and quality of life after iatrogenic cerebral air embolism treated with hyperbaric oxygen: a prospective cohort study.

Diving and hyperbaric medicine·2025
Same author

Clostridial Myonecrosis (Gas Gangrene).

Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc·2025
Same author

Shared decision-making when considering hyperbaric oxygen therapy: a systematic review.

Diving and hyperbaric medicine·2025

Related Experiment Video

Updated: May 30, 2026

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

To dive or not to dive with bleomycin: a practical algorithm.

Robert A van Hulst1, Ronald C Rietbroek, Menno T W Gaastra

  • 1Maritime Medical Expertise Center, Royal Netherlands Navy, Den Helder, The Netherlands. ravhulst@planet.nl

Aviation, Space, and Environmental Medicine
|August 23, 2011
PubMed
Summary
This summary is machine-generated.

A new algorithm helps determine fitness for scuba diving after bleomycin cancer treatment. Most patients, especially those with testicular cancer, are cleared for diving, but Hodgkin's disease patients may face higher risks.

More Related Videos

A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis
05:45

A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis

Published on: January 16, 2026

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
09:02

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

Related Experiment Videos

Last Updated: May 30, 2026

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis
05:45

A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis

Published on: January 16, 2026

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
09:02

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

Area of Science:

  • Oncology
  • Diving Medicine
  • Pulmonary Medicine

Background:

  • Bleomycin cancer treatment can cause lung damage (interstitial pneumonitis and fibrosis).
  • High oxygen levels in scuba diving may exacerbate bleomycin-induced lung toxicity.
  • This creates a clinical dilemma regarding fitness for scuba diving after bleomycin therapy.

Purpose of the Study:

  • To develop and evaluate an algorithm for assessing scuba diving fitness in patients treated with bleomycin.
  • To identify patient groups at higher risk for diving contraindications post-bleomycin therapy.

Main Methods:

  • A survey-based evaluation of 16 cancer patients (testicular/germ cell cancer or Hodgkin's disease) treated with bleomycin.
  • Algorithm development based on a literature review spanning oncology, anesthesiology, and diving medicine.
  • Assessment of patient fitness for scuba diving using the developed algorithm.

Main Results:

  • 12 out of 16 surveyed patients were deemed fit for scuba diving.
  • A significant difference in fitness was observed between cancer types: 10 of 11 testicular/germ cell cancer patients were fit, compared to only 2 of 5 Hodgkin's disease patients.
  • Patients with Hodgkin's disease showed a lower fitness rate for scuba diving.

Conclusions:

  • The developed algorithm provides a framework for physicians and diving organizations to assess scuba diving fitness post-bleomycin treatment.
  • Patients with Hodgkin's disease, particularly those receiving combined bleomycin and radiation therapy, may have an elevated risk of pulmonary complications, potentially rendering them unfit for diving.
  • Further risk stratification is necessary for specific patient populations, especially those with a history of radiation therapy.